1. Home
  2. III vs CCCC Comparison

III vs CCCC Comparison

Compare III & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.34

Market Cap

187.8M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.97

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
CCCC
Founded
2006
2015
Country
United States
United States
Employees
1500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.8M
185.1M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
III
CCCC
Price
$4.34
$2.97
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$5.50
$12.20
AVG Volume (30 Days)
201.1K
2.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
4.16%
N/A
EPS Growth
216.67
16.45
EPS
0.19
N/A
Revenue
$192,745,000.00
$35,947,000.00
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.34
N/A
P/E Ratio
$22.84
N/A
Revenue Growth
4.51
1.02
52 Week Low
$3.57
$1.21
52 Week High
$6.45
$3.82

Technical Indicators

Market Signals
Indicator
III
CCCC
Relative Strength Index (RSI) 60.10 56.63
Support Level $4.12 $2.30
Resistance Level $5.14 $3.82
Average True Range (ATR) 0.12 0.23
MACD 0.08 0.02
Stochastic Oscillator 92.87 79.13

Price Performance

Historical Comparison
III
CCCC

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: